With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Michael Kremer is a non-resident fellow at the Center for Global Development, the University Professor in Economics and Director of the Development Innovation Lab at the University of Chicago, a senior fellow at the Brookings Institution, and a 2019 co-recipient of the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel. He is a fellow of the American Academy of Arts and Sciences, a recipient of a MacArthur Fellowship and a Presidential Faculty Fellowship, and was named a young global leader by the World Economic Forum. Kremer’s recent research examines education and health in developing countries, immigration, and globalization. He and Rachel Glennerster published Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, which won the Association of American Publishers Award for the Best Professional/Scholarly Book in Medical Science in 2004. He is a 2005 recipient of the International Health Economics Association’s Kenneth J. Arrow Award for best paper in health economics. In 2006, Scientific American named him one of the 50 researchers of the year.
The debate on user fees in health and education has been contentious, but until recently much of the evidence has been anecdotal. Does charging poor people for health and education services improve or impede access? CGD non-resident fellow Michael Kremer and co-author Alaka Holla survey the evidence from recent randomized evaluations across a variety of settings to find out. The verdict: higher prices decrease access.
Diarrheal diseases kill two million children a year in poor countries. Vaccination, oral rehydration therapy, breastfeeding, and micronutrient supplementation have been effective in saving lives but the continuing toll suggests that further investments are needed. In this CGD working paper, non-resident fellow Michael Kremer and his co-author critically review existing research and identify research priorities to reduce the impact of the disease.
As the GAVI Alliance gears up for its pledging conference in June, a CGD panel reflected on progress and lessons learned in financing GAVI since 2001 and explored implications for the next decade. Speakers had first-hand experience in the design and implementation of the major vaccine financing instruments—Alice Albright, former CFO of GAVI; Michael Kremer, co-chair of CGD’s Advance Market Commitment (AMC) Working Group; Helen Evans and David Ferreira, GAVI; and Amie Batson, Deputy Assistant Administrator for Global Health at USAID. Key takeaways from the event are directly below, and a longer summary—with embedded video clips—is below that. You can also watch a full recording of the event here.
November 12th is fast approaching and with it comes world pneumonia day. Unfortunately, pneumococcal diseases still pose an enormous global threat--remaining the leading cause of death for children worldwide and taking the lives of 1.4 million children under five years annually. What’s more—a staggering 98% of these children live in developing countries.